Kaposi’s sarcoma facilitates the diagnosis of Castleman’s disease in a patient living with HIV

Authors

  • Fernando Oliveira e Silva Centro Hospitalar Universitário de São João, Doenças Infeciosas - Porto - Portugal
  • César Cilento Ponce Instituto de Infectologia Emílio Ribas, Patologia Clínica - São Paulo - Brasil
  • Rosely Antunes Patzina Instituto de Infectologia Emílio Ribas, Patologia Clínica - São Paulo - Brasil
  • Edgar de Bortholi Santos Instituto de Infectologia Emílio Ribas - São Paulo - Brasil

DOI:

https://doi.org/10.5935/2764-734X.e20230325-pt

Keywords:

Kaposi sarcoma, Human Herpesvirus 8, HIV, Giant lymph node hyperplasia, Case report

Abstract

Diseases caused by human herpesvirus 8 (HHV-8) can affect immunosuppressed patients, particularly those co-infected with the human immunodeficiency virus (HIV). Castleman disease is one such condition that is rare and challenging to diagnose, given its numerous nonspecific symptoms and multiple differential diagnoses. This study reports a case of a patient living with HIV who was diagnosed with multicentric Castleman disease, wherein the diagnosis was facilitated by the concomitant presence of Kaposi sarcoma in the gastrointestinal tract, both of which are directly related to HHV-8 infection.

References

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994 Dez;266(5192):1865-9.

2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based

3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995 Ago;86(4):1276-80.

4. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011 Out;118(15):4041-52.

5. Freitas RB, Freitas MR, Linhares AC. Prevalence of human herpesvirus 8 antibodies in the population of Belém, Pará, Brazil. Rev Inst Med Trop S Paulo. 2002 Dez;44(6):309-13.

6. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 2000 Mai;181(5):1562-8.

7. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998 Abr;338(14):948-54.

8. Plancoulaine S, Abel L, Van Beveren M, Tregouet DA, Joubert M, Tortevoye P, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000 Set/Out;356(9235):1062-5.

9. Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 2002 Mar;287(10):1295-3000.

10. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002 Mai;2(5):281-92.

11. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006 Ago;20(12):1645-54.

12. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956 Jul;9(4):822-30.

13. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978 Jan;69(1):86-90.

14. Bower M, Newsom-Davis T, Naresh K, Merchant S, Lee B, Gazzard B, et al. Clinical features and outcome in HIV-associated multicentric Castleman’s disease. J Clin Oncol. 2011 Jun;29(18):2481-6.

15. Collins LS, Fowler A, Tong CY, Ruiter A. Multicentric Castleman’s disease in HIV infection. Int J STD AIDS. 2006 Jan;17(1):19-24;quiz:5.

16. Guihot A, Couderc LJ, Rivaud E, Galicier L, Bossi P, Oksenhendler E, et al. Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients. J Thorac Imaging. 2007 Mai;22(2):207-11.

17. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000 Fev;95(4):1406-12.

18. Ramaswami R, Lurain K, Polizzotto MN, Ekwede I, Waldon K, Steinberg SM, et al. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. Blood Adv. 2021 Mar;5(6):1660-70.

19. Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, et al. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood. 2014 Dez;124(24):3544-52.

20. Uldrick TS, Wang V, O’Mahony D, Aleman K, Wyvill KM, Marshall V, et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis. 2010 Ago;51(3):350-8.

21. Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, et al. Clinical features and outcomes of patients with symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin Infect Dis. 2016 Mar;62(6):730-8.

22. Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010 Jan;16(Supl 1):S82-S9.

Downloads

Published

2023-05-12

How to Cite

Silva, F. O. e, Ponce, C. C., Patzina, R. A., & Santos, E. de B. (2023). Kaposi’s sarcoma facilitates the diagnosis of Castleman’s disease in a patient living with HIV. Infections in Evidence, 2, e20230325. https://doi.org/10.5935/2764-734X.e20230325-pt

Issue

Vol. 2 (2023)

Section

Case Reports

License

Copyright (c) 2023 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.